Product information

From Health Canada

Current status:

Approved

Current status date:

2021-06-02

Product name:

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A

Description:

FOR USE WITH APHERESIS DEVICE ONLY

DIN:

02516675 Electronic product monograph is not available

Company:

FRESENIUS KABI AG
Else-Kroner-Strasse 1
Bad Homburg
Hessen
Germany 61346

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

0-Unassigned

Number of active ingredient(s):

3

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

20:12.04.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:See footnote5

0300464004

List of active ingredient(s)
Active ingredient(s) Strength
CITRIC ACID 770 MG / 100 ML
DEXTROSE 2.54 G / 100 ML
SODIUM CITRATE 2.14 G / 100 ML
Version 4.0.2
Date modified: